MTL - BROCHURE 2018 SINGLE PAGES
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
❝Whenever a company had a problem, Mark was the person<br />
to provide the solution, rather than just a temporary patch.❞<br />
<strong>MTL</strong> - Projects<br />
Stan O’Neill, Managing Director, The Compliance Group<br />
ASTM E2500 and many other recent standards and<br />
guidance documents require the proper application of<br />
Good Engineering Practice (GEP) and Subject Matter<br />
Expertise (SME) throughout Projects. Mark Thompson<br />
Lifesciences deliver this in a number of areas.<br />
Recent updates to Annex 15 of the EU GMP guide<br />
Projects undertaken<br />
also require a much more detailed and considered<br />
approach to process risk assessments, design<br />
qualification (DQ) and requirements traceability<br />
matrices (RTM) on projects. When applied properly,<br />
this approach delivers huge benefits to the quality and<br />
understanding of the delivered process.<br />
PROJECT LOCATION DELIVERABLES<br />
New Parenteral product<br />
Formulation and Aseptic Fill<br />
Finish facility<br />
Facility Expansion Project for<br />
Terminal Sterilisation Facility<br />
Sterilisation Process<br />
Improvement on Aseptic Fill<br />
Finish Facility<br />
New Filling Line in Parenteral<br />
Product Facility for both Aseptic<br />
and Terminally Sterilised<br />
Products<br />
New High Purity Water System;<br />
Generation Storage and<br />
Distribution for a 45m3/Hr High<br />
Purity Water System<br />
High Purity Water System<br />
Upgrade. 18MOhm water<br />
system generation storage and<br />
distribution<br />
Ireland<br />
Ireland<br />
UK<br />
UK<br />
China<br />
UK<br />
Consultancy Support and Project Guidance throughout including the<br />
Contamination Control Process Risk Assessment, URS development,<br />
Design Qualification and Requirements Traceability Matrix<br />
Consultancy Support to Sterility Assurance Risk Assessment and<br />
Qualification approach to Sterilisation in Place Processes<br />
Audit and Process Review to ensure regulatory compliance and<br />
identify action plans for process improvement. Training and<br />
development of site expertise and Subject Matter Expertise in:-<br />
• Sterilisation and Depyrogenation<br />
• Pharmaceutical Engineering<br />
• Steam Quality Testing<br />
Contamination Control and Cross Contamination Control Process<br />
Risk Assessment. Development of Validation Master Plan, Validation<br />
approach and scoping the qualification activities based upon Process<br />
Risk Assessment and Design Qualifications<br />
URS Development, Supplier Auditing, Design Qualification and<br />
Project support throughout Validation. This project run in conjunction<br />
with Crystal Clear Engineering, delivered and led by <strong>MTL</strong><br />
Consultancy support to scope the most appropriate project solution,<br />
URS Development and ongoing consultancy support. This project run<br />
in conjunction with Crystal Clear Engineering, delivered and led by<br />
<strong>MTL</strong><br />
Critical Utilities System Review Netherlands Aged Plant analysis and Critical Utilities Review in response to FDA<br />
observation<br />
Steriliser Upgrade Project to<br />
meet current GMP and EU<br />
standards for Sterilisation<br />
Processes.<br />
Pre US FDA Inspection of<br />
Aseptic Fill Finish Facility<br />
Biological Indicator Receipt<br />
verification. D value testing<br />
Bio burden Control and Micro<br />
biology control improvements<br />
Belgium<br />
India<br />
3 sites in<br />
Ireland and 1<br />
in UK<br />
Brazil<br />
Consultancy Support and Training for Upgrade Project. On site cycle<br />
development and air detector set up work<br />
Pre Audit inspection and consultancy support in preparation for first<br />
site FDA inspection<br />
Receipt verification of Biological Indicators is defined in USP and<br />
EP. Performing independent D value determination is problematic<br />
so many sites are changing to running a sub lethal cycle which is in<br />
full compliance with EP and USP requirements. Project and Change<br />
control assistance being supplied to drive through the change.<br />
Project Delivered for the Gates Foundation at a vaccine manufacturer<br />
in Brazil